1. Korea Central Cancer Registry. 2012 Statistics on the national cancer registry. Goyang: National Cancer Center;2014.
2. National Lung Screening Trial Research Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365:395–409.
3. Moyer VA. US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160:330–338.
4. Kazerooni EA, Armstrong MR, Amorosa JK, Hernandez D, Liebscher LA, Nath H, McNitt-Gray MF, Stern EJ, Wilcox PA. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol. 2015; 12:38–42.
6. Lee HJ, Kim JH, Kim YK, Park CM, Yi CA, Jeong YJ. Korean Society of Thoracic Radiology guideline for lung cancer screening with low-dose CT. J Korean Soc Radiol. 2012; 67:349–365.
7. Korean National Cancer Screening Guideline Revision Committee. The Korean guideline for lung cancer screening (the first draft). Seoul: Korean National Cancer Screening Guideline Revision Committee;2014.
8. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev. 2013; 6:CD001991.
9. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143:e78S–e92S.
10. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Errico V, Inzirillo F, Bottoni E, Voulaz E, Alloisio M, Destro A, Roncalli M, Santoro A, Ravasi G. DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009; 180:445–453.
11. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Dossing M, Hansen H, Kofoed KF, Larsen KR, Mortensen J, Rasmussen JF, Seersholm N, Skov BG, Thorsen H, Tonnesen P, Pedersen JH. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012; 67:296–301.
12. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012; 21:308–315.
13. International Early Lung Cancer Action Program Investigators. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355:1763–1771.
14. Lee HJ, Kim JH, Kim YK, Park CM, Yi CA, Jeong YJ. Lung cancer screening with low-dose CT: potential benefits and potential harms. J Korean Soc Thorac Radiol. 2012; 1 Suppl. S1–S7.
15. Kazerooni EA, Austin JH, Black WC, Dyer DS, Hazelton TR, Leung AN, McNitt-Gray MF, Munden RF, Pipavath S. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging. 2014; 29:310–316.
17. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307:2418–2429.
18. No. 65. Regulations for Installation and Management of Special Medical Equipmen, Pub. L. 2011. 06. 27.
19. Korean Society of Radiology. Guidelines for quality assurance of CT. The Korean Society of Radiology. Guidelines for quality assurance of special medical equipment. Seoul: Korean Society of Radiology;2013. p. 12–28.
20. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC. American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132:94S–107S.
21. McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2015; 12:273–276.
22. Van Hamersvelt RW, Willemink MJ, Takx RA, Eikendal AL, Budde RP, Leiner T, Mol CP, Isgum I, de Jong PA. Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability. Eur Radiol. 2014; 24:1557–1564.
23. Jacobs PC, Prokop M, van der Graaf Y, Gondrie MJ, Janssen KJ, de Koning HJ, Isgum I, van Klaveren RJ, Oudkerk M, van Ginneken B, Mali WP. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis. 2010; 209:455–462.
24. Prokop M. Lung cancer screening: the radiologis's perspective. Semin Respir Crit Care Med. 2014; 35:91–98.
25. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, Chiles C, Black WC, Aberle DR. NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014; 174:269–274.
26. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Mandrekar JN. 5-Year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest. 2009; 136:1586–1595.
27. Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013; 310:797–798.
28. McCunney RJ, Li J. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors. Chest. 2014; 145:618–624.
29. Lee SM, Lee HJ. Low-dose CT for lung cancer screening: radiation risk. J Korean Soc Thorac Radiol. 2012; 1 Suppl. S8–S11.